img

Global Coagulation Factor XI Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Coagulation Factor XI Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Coagulation Factor XI report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Coagulation Factor XI market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Thrombosis and Bleeding and Clotting Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Coagulation Factor XI industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Coagulation Factor XI key companies include Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc. and LegoChem Biosciences, Inc, etc. Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC are top 3 players and held % share in total in 2022.
Coagulation Factor XI can be divided into MR-1007, IONIS-FXIRx, EP-7041 and AB-022, etc. MR-1007 is the mainstream product in the market, accounting for % share globally in 2022.
Coagulation Factor XI is widely used in various fields, such as Thrombosis, Bleeding and Clotting Disorders, Acute Ischemic Stroke and Others, etc. Thrombosis provides greatest supports to the Coagulation Factor XI industry development. In 2022, global % share of Coagulation Factor XI went into Thrombosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Coagulation Factor XI market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
Segment by Type
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others

Segment by Application


Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Coagulation Factor XI market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Coagulation Factor XI introduction, etc. Coagulation Factor XI Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Coagulation Factor XI market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Coagulation Factor XI
1.1 Coagulation Factor XI Market Overview
1.1.1 Coagulation Factor XI Product Scope
1.1.2 Coagulation Factor XI Market Status and Outlook
1.2 Global Coagulation Factor XI Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Coagulation Factor XI Market Size by Region (2018-2034)
1.4 Global Coagulation Factor XI Historic Market Size by Region (2018-2024)
1.5 Global Coagulation Factor XI Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Coagulation Factor XI Market Size (2018-2034)
1.6.1 North America Coagulation Factor XI Market Size (2018-2034)
1.6.2 Europe Coagulation Factor XI Market Size (2018-2034)
1.6.3 Asia-Pacific Coagulation Factor XI Market Size (2018-2034)
1.6.4 Latin America Coagulation Factor XI Market Size (2018-2034)
1.6.5 Middle East & Africa Coagulation Factor XI Market Size (2018-2034)
2 Coagulation Factor XI Market by Type
2.1 Introduction
2.1.1 MR-1007
2.1.2 IONIS-FXIRx
2.1.3 EP-7041
2.1.4 AB-022
2.1.5 BMS-262084
2.1.6 Others
2.2 Global Coagulation Factor XI Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Coagulation Factor XI Historic Market Size by Type (2018-2024)
2.2.2 Global Coagulation Factor XI Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Coagulation Factor XI Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Coagulation Factor XI Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Coagulation Factor XI Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Coagulation Factor XI Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Coagulation Factor XI Revenue Breakdown by Type (2018-2034)
3 Coagulation Factor XI Market Overview by Application
3.1 Introduction
3.1.1 Thrombosis
3.1.2 Bleeding and Clotting Disorders
3.1.3 Acute Ischemic Stroke
3.1.4 Others
3.2 Global Coagulation Factor XI Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Coagulation Factor XI Historic Market Size by Application (2018-2024)
3.2.2 Global Coagulation Factor XI Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Coagulation Factor XI Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Coagulation Factor XI Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Coagulation Factor XI Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Coagulation Factor XI Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Coagulation Factor XI Revenue Breakdown by Application (2018-2034)
4 Coagulation Factor XI Competition Analysis by Players
4.1 Global Coagulation Factor XI Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coagulation Factor XI as of 2022)
4.3 Date of Key Players Enter into Coagulation Factor XI Market
4.4 Global Top Players Coagulation Factor XI Headquarters and Area Served
4.5 Key Players Coagulation Factor XI Product Solution and Service
4.6 Competitive Status
4.6.1 Coagulation Factor XI Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer AG
5.1.1 Bayer AG Profile
5.1.2 Bayer AG Main Business
5.1.3 Bayer AG Coagulation Factor XI Products, Services and Solutions
5.1.4 Bayer AG Coagulation Factor XI Revenue (US$ Million) & (2018-2024)
5.1.5 Bayer AG Recent Developments
5.2 Bristol-Myers Squibb Company
5.2.1 Bristol-Myers Squibb Company Profile
5.2.2 Bristol-Myers Squibb Company Main Business
5.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Products, Services and Solutions
5.2.4 Bristol-Myers Squibb Company Coagulation Factor XI Revenue (US$ Million) & (2018-2024)
5.2.5 Bristol-Myers Squibb Company Recent Developments
5.3 Cambryn Biologics LLC
5.3.1 Cambryn Biologics LLC Profile
5.3.2 Cambryn Biologics LLC Main Business
5.3.3 Cambryn Biologics LLC Coagulation Factor XI Products, Services and Solutions
5.3.4 Cambryn Biologics LLC Coagulation Factor XI Revenue (US$ Million) & (2018-2024)
5.3.5 eXithera Pharmaceuticals, Inc Recent Developments
5.4 eXithera Pharmaceuticals, Inc
5.4.1 eXithera Pharmaceuticals, Inc Profile
5.4.2 eXithera Pharmaceuticals, Inc Main Business
5.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Products, Services and Solutions
5.4.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue (US$ Million) & (2018-2024)
5.4.5 eXithera Pharmaceuticals, Inc Recent Developments
5.5 Ionis Pharmaceuticals, Inc.
5.5.1 Ionis Pharmaceuticals, Inc. Profile
5.5.2 Ionis Pharmaceuticals, Inc. Main Business
5.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Products, Services and Solutions
5.5.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue (US$ Million) & (2018-2024)
5.5.5 Ionis Pharmaceuticals, Inc. Recent Developments
5.6 LegoChem Biosciences, Inc
5.6.1 LegoChem Biosciences, Inc Profile
5.6.2 LegoChem Biosciences, Inc Main Business
5.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Products, Services and Solutions
5.6.4 LegoChem Biosciences, Inc Coagulation Factor XI Revenue (US$ Million) & (2018-2024)
5.6.5 LegoChem Biosciences, Inc Recent Developments
6 North America
6.1 North America Coagulation Factor XI Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Coagulation Factor XI Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Coagulation Factor XI Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Coagulation Factor XI Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Coagulation Factor XI Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Coagulation Factor XI Market Dynamics
11.1 Coagulation Factor XI Industry Trends
11.2 Coagulation Factor XI Market Drivers
11.3 Coagulation Factor XI Market Challenges
11.4 Coagulation Factor XI Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Coagulation Factor XI Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Coagulation Factor XI Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Coagulation Factor XI Market Size Share by Region (2018-2024)
Table 4. Global Coagulation Factor XI Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Coagulation Factor XI Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Coagulation Factor XI Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Coagulation Factor XI Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Coagulation Factor XI Revenue Market Share by Type (2018-2024)
Table 9. Global Coagulation Factor XI Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Coagulation Factor XI Revenue Market Share by Type (2024-2034)
Table 11. North America Coagulation Factor XI Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Coagulation Factor XI Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Coagulation Factor XI Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Coagulation Factor XI Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Coagulation Factor XI Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Coagulation Factor XI Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Coagulation Factor XI Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Coagulation Factor XI Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Coagulation Factor XI Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Coagulation Factor XI Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Coagulation Factor XI Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Coagulation Factor XI Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Coagulation Factor XI Revenue Market Share by Application (2018-2024)
Table 24. Global Coagulation Factor XI Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Coagulation Factor XI Revenue Market Share by Application (2024-2034)
Table 26. North America Coagulation Factor XI Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Coagulation Factor XI Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Coagulation Factor XI Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Coagulation Factor XI Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Coagulation Factor XI Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Coagulation Factor XI Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Coagulation Factor XI Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Coagulation Factor XI Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Coagulation Factor XI Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Coagulation Factor XI Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Coagulation Factor XI Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Coagulation Factor XI Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coagulation Factor XI as of 2022)
Table 39. Date of Key Players Enter into Coagulation Factor XI Market
Table 40. Global Coagulation Factor XI Key Players Headquarters and Area Served
Table 41. Coagulation Factor XI Product Solution and Service
Table 42. Global Coagulation Factor XI Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bayer AG Basic Information List
Table 45. Bayer AG Description and Business Overview
Table 46. Bayer AG Coagulation Factor XI Products, Services and Solutions
Table 47. Revenue (US$ Million) in Coagulation Factor XI Business of Bayer AG (2018-2024)
Table 48. Bayer AG Recent Developments
Table 49. Bristol-Myers Squibb Company Basic Information List
Table 50. Bristol-Myers Squibb Company Description and Business Overview
Table 51. Bristol-Myers Squibb Company Coagulation Factor XI Products, Services and Solutions
Table 52. Revenue (US$ Million) in Coagulation Factor XI Business of Bristol-Myers Squibb Company (2018-2024)
Table 53. Bristol-Myers Squibb Company Recent Developments
Table 54. Cambryn Biologics LLC Basic Information List
Table 55. Cambryn Biologics LLC Description and Business Overview
Table 56. Cambryn Biologics LLC Coagulation Factor XI Products, Services and Solutions
Table 57. Revenue (US$ Million) in Coagulation Factor XI Business of Cambryn Biologics LLC (2018-2024)
Table 58. Cambryn Biologics LLC Recent Developments
Table 59. eXithera Pharmaceuticals, Inc Basic Information List
Table 60. eXithera Pharmaceuticals, Inc Description and Business Overview
Table 61. eXithera Pharmaceuticals, Inc Coagulation Factor XI Products, Services and Solutions
Table 62. Revenue (US$ Million) in Coagulation Factor XI Business of eXithera Pharmaceuticals, Inc (2018-2024)
Table 63. eXithera Pharmaceuticals, Inc Recent Developments
Table 64. Ionis Pharmaceuticals, Inc. Basic Information List
Table 65. Ionis Pharmaceuticals, Inc. Description and Business Overview
Table 66. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Products, Services and Solutions
Table 67. Revenue (US$ Million) in Coagulation Factor XI Business of Ionis Pharmaceuticals, Inc. (2018-2024)
Table 68. Ionis Pharmaceuticals, Inc. Recent Developments
Table 69. LegoChem Biosciences, Inc Basic Information List
Table 70. LegoChem Biosciences, Inc Description and Business Overview
Table 71. LegoChem Biosciences, Inc Coagulation Factor XI Products, Services and Solutions
Table 72. Revenue (US$ Million) in Coagulation Factor XI Business of LegoChem Biosciences, Inc (2018-2024)
Table 73. LegoChem Biosciences, Inc Recent Developments
Table 74. North America Coagulation Factor XI Market Size by Country (2018-2024) & (US$ Million)
Table 75. North America Coagulation Factor XI Market Size by Country (2024-2034) & (US$ Million)
Table 76. Europe Coagulation Factor XI Market Size by Country (2018-2024) & (US$ Million)
Table 77. Europe Coagulation Factor XI Market Size by Country (2024-2034) & (US$ Million)
Table 78. Asia-Pacific Coagulation Factor XI Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 79. Asia-Pacific Coagulation Factor XI Market Size by Region (2018-2024) & (US$ Million)
Table 80. Asia-Pacific Coagulation Factor XI Market Size by Region (2024-2034) & (US$ Million)
Table 81. Asia-Pacific Coagulation Factor XI Market Share by Region (2018-2024)
Table 82. Asia-Pacific Coagulation Factor XI Market Share by Region (2024-2034)
Table 83. Latin America Coagulation Factor XI Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 84. Latin America Coagulation Factor XI Market Size by Country (2018-2024) & (US$ Million)
Table 85. Latin America Coagulation Factor XI Market Size by Country (2024-2034) & (US$ Million)
Table 86. Middle East & Africa Coagulation Factor XI Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 87. Middle East & Africa Coagulation Factor XI Market Size by Country (2018-2024) & (US$ Million)
Table 88. Middle East & Africa Coagulation Factor XI Market Size by Country (2024-2034) & (US$ Million)
Table 89. Coagulation Factor XI Market Trends
Table 90. Coagulation Factor XI Market Drivers
Table 91. Coagulation Factor XI Market Challenges
Table 92. Coagulation Factor XI Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Coagulation Factor XI Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Coagulation Factor XI Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Coagulation Factor XI Market Share by Regions: 2022 VS 2034
Figure 4. Global Coagulation Factor XI Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Coagulation Factor XI Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Coagulation Factor XI Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Coagulation Factor XI Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Coagulation Factor XI Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Coagulation Factor XI Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of MR-1007
Figure 11. Global MR-1007 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of IONIS-FXIRx
Figure 13. Global IONIS-FXIRx Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of EP-7041
Figure 15. Global EP-7041 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of AB-022
Figure 17. Global AB-022 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of BMS-262084
Figure 19. Global BMS-262084 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Product Picture of Others
Figure 21. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. Global Coagulation Factor XI Market Size Share by Type: 2022 & 2034
Figure 23. North America Coagulation Factor XI Revenue Market Share by Type (2018-2034)
Figure 24. Europe Coagulation Factor XI Revenue Market Share by Type (2018-2034)
Figure 25. Asia-Pacific Coagulation Factor XI Revenue Market Share by Type (2018-2034)
Figure 26. Latin America Coagulation Factor XI Revenue Market Share by Type (2018-2034)
Figure 27. Middle East and Africa Coagulation Factor XI Revenue Market Share by Type (2018-2034)
Figure 28. Thrombosis Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Bleeding and Clotting Disorders Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 30. Acute Ischemic Stroke Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 31. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 32. Global Coagulation Factor XI Market Size Share by Application: 2022 & 2034
Figure 33. North America Coagulation Factor XI Revenue Market Share by Application (2018-2034)
Figure 34. Europe Coagulation Factor XI Revenue Market Share by Application (2018-2034)
Figure 35. Asia-Pacific Coagulation Factor XI Revenue Market Share by Application (2018-2034)
Figure 36. Latin America Coagulation Factor XI Revenue Market Share by Application (2018-2034)
Figure 37. Middle East and Africa Coagulation Factor XI Revenue Market Share by Application (2018-2034)
Figure 38. Coagulation Factor XI Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 39. Global Top 5 and Top 10 Players Coagulation Factor XI Market Share in 2022
Figure 40. North America Coagulation Factor XI Market Share by Country (2018-2034)
Figure 41. U.S. Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 42. Canada Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 43. Germany Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 44. France Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 45. U.K. Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 46. Italy Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 47. Russia Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 48. Nordic Countries Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 49. Asia-Pacific Coagulation Factor XI Market Share by Region (2018-2034)
Figure 50. China Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 51. Japan Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 52. South Korea Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 53. Southeast Asia Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 54. India Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 55. Australia Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 56. Latin America Coagulation Factor XI Market Share by Country (2018-2034)
Figure 57. Mexico Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 58. Brazil Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 59. Middle East & Africa Coagulation Factor XI Market Share by Country (2018-2034)
Figure 60. Turkey Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 61. Saudi Arabia Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 62. UAE Coagulation Factor XI Market Size (2018-2034) & (US$ Million)
Figure 63. Bottom-up and Top-down Approaches for This Report